OMass Therapeutics, an Oxford spin-out built on native mass spectrometry, has raised £230 million (about $310 million) in a Series C that CEO ...

Getting pet hair out of carpets and off of tile and hardwood is a constant battle many are familiar with, and trying to remove those persistent hairs that have embedded themselves into your upholstery ...

On Monday, Salvador Illa posted a tweet on the X network to protest against the approach of the program Vertex for having ...

Children aged 6-11 years with moderate-to-severe asthma with type 2 inflammation who were treated with dupilumab were at least twice as likely to achieve clinical remission after 1 year compared to ...

Hurricane Isaias is forecast to miss the oil industry’s biggest hubs along the Gulf Coast. But industry experts say it could ...

Lindsey Vonn recovering and promoting Journavx, a non-opioid painkiller she was able to take after her ski-racing crash at the 2026 Winter Olympics.

Vertex stock popped Tuesday — while shares of rival Maze Therapeutics (MAZE) skyrocketed — on a surprise expansion for their kidney disease drugs. Both companies are working on treatments for ...

Vertex plans to discuss the data with regulators in the context of the pivotal Amplitude trial. (Joseph Prezioso/AFP/Getty Images) Vertex has reported positive phase 2b data for its kidney disease ...

Here's the best part. Vertex Pharmaceuticals won't lose patent exclusivity for its most important CF products until the late 2030s. In the meantime, the company is diversifying its lineup. It has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Image source: The Motley Fool. Vertex Pharmaceuticals doesn't have a long list of products like many of its similarly sized peers in the biotech industry. That's because it doesn't need to. The ...

Every grid operator running a wind farm or solar field makes dozens of dispatch decisions each day based on a single piece of information: what will the sky do in the next few hours? Until now, the ...